DK1638539T3 - Farmaceutiske sammensætninger omfattende pH-sensitive blokcopolymerer og et hydrofobisk medikament - Google Patents

Farmaceutiske sammensætninger omfattende pH-sensitive blokcopolymerer og et hydrofobisk medikament

Info

Publication number
DK1638539T3
DK1638539T3 DK04727195T DK04727195T DK1638539T3 DK 1638539 T3 DK1638539 T3 DK 1638539T3 DK 04727195 T DK04727195 T DK 04727195T DK 04727195 T DK04727195 T DK 04727195T DK 1638539 T3 DK1638539 T3 DK 1638539T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
block copolymers
poly
alkyl
hydrophobic drug
Prior art date
Application number
DK04727195T
Other languages
Danish (da)
English (en)
Inventor
Vinayak Sant
Jean-Christophe Leroux
Original Assignee
Univ Montreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Montreal filed Critical Univ Montreal
Application granted granted Critical
Publication of DK1638539T3 publication Critical patent/DK1638539T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
DK04727195T 2003-06-25 2004-04-14 Farmaceutiske sammensætninger omfattende pH-sensitive blokcopolymerer og et hydrofobisk medikament DK1638539T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/607,446 US7094810B2 (en) 2001-06-08 2003-06-25 pH-sensitive block copolymers for pharmaceutical compositions
PCT/CA2004/000561 WO2004112757A1 (fr) 2003-06-25 2004-04-14 Compositions pharmaceutiques contenant des copolymeres sequences sensibles au ph et un medicament hydrophobe

Publications (1)

Publication Number Publication Date
DK1638539T3 true DK1638539T3 (da) 2009-05-04

Family

ID=33540273

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04727195T DK1638539T3 (da) 2003-06-25 2004-04-14 Farmaceutiske sammensætninger omfattende pH-sensitive blokcopolymerer og et hydrofobisk medikament

Country Status (16)

Country Link
US (1) US7094810B2 (fr)
EP (1) EP1638539B1 (fr)
JP (1) JP4619357B2 (fr)
AT (1) ATE418970T1 (fr)
AU (1) AU2004248863B2 (fr)
BR (1) BRPI0411872A (fr)
CA (1) CA2530736C (fr)
CY (1) CY1110264T1 (fr)
DE (1) DE602004018772D1 (fr)
DK (1) DK1638539T3 (fr)
ES (1) ES2323701T3 (fr)
MX (1) MXPA05014017A (fr)
PL (1) PL1638539T3 (fr)
PT (1) PT1638539E (fr)
SI (1) SI1638539T1 (fr)
WO (1) WO2004112757A1 (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523544A (ja) * 2000-02-17 2003-08-05 レックスマーク・インターナショナル・インコーポレーテツド 導電性駆動ハブを備えたトナーカートリッジ
US6939564B2 (en) * 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
WO2005079856A1 (fr) * 2004-02-23 2005-09-01 The University Of British Columbia Compositions de medicaments contenant des polymeres hydrophobes et des molecules amphipathiques
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
WO2008002568A2 (fr) * 2006-06-26 2008-01-03 Mutual Pharmaceutical Company, Inc. Formulations d'agent actif, procédé d'élaboration et d'utilisation
US20090074872A1 (en) * 2006-06-26 2009-03-19 Mutual Pharmaceutical Company, Inc. Active Agent Formulations, Methods of Making, and Methods of Use
MX2009003092A (es) * 2006-09-22 2009-05-08 Labopharm Inc Composiciones y metodos para suministro de farmaco dirigido a ph.
WO2008079677A2 (fr) * 2006-12-20 2008-07-03 Arkema Inc. Polymères d'encapsulation et/ou de liaison
US20100136124A1 (en) * 2007-04-20 2010-06-03 University Of South Australia Nanoparticle-coated capsule formulation for dermal drug delivery
KR20100065190A (ko) * 2007-09-14 2010-06-15 닛토덴코 가부시키가이샤 약물 담체
FR2922452B1 (fr) * 2007-10-19 2010-01-22 Coatex Sas Formulations de composes organoplatiniques en presence de polymeres associatifs, produits obtenus et leurs utilisations
TWI388591B (zh) * 2008-03-28 2013-03-11 Ind Tech Res Inst 溫度敏感性材料
US8778400B2 (en) * 2008-04-21 2014-07-15 University Of South Australia Nanoparticle-stabilized capsule formulation for treatment of inflammation
US20110142951A1 (en) * 2008-05-13 2011-06-16 University Of Washington Micelles for intracellular delivery of therapeutic agents
CN103342789B (zh) 2008-05-13 2016-11-23 华盛顿大学 用于向细胞内递送的二嵌段共聚物和其多核苷酸复合物
KR101764427B1 (ko) * 2008-05-13 2017-08-02 유니버시티 오브 워싱톤 미셀성 어셈블리
US20110129921A1 (en) * 2008-05-13 2011-06-02 University Of Washington Targeted polymer bioconjugates
WO2009140421A2 (fr) * 2008-05-13 2009-11-19 University Of Washington Vecteur polymère
NZ589287A (en) * 2008-05-16 2012-06-29 Univ Sydney Administrable compositions
CA2635187A1 (fr) 2008-06-05 2009-12-05 The Royal Institution For The Advancement Of Learning/Mcgill University Duplex d'oligonucleotides et leurs utilisations
DK2305275T3 (da) * 2008-06-24 2013-10-07 Nanocarrier Co Ltd Væskesammensætning omfattende cisplatinkoordinerende forbindelse
WO2010021770A1 (fr) 2008-08-22 2010-02-25 University Of Washington Micelles polymères hétérogènes pour administration intracellulaire
EP2364330B1 (fr) 2008-11-06 2015-03-25 University Of Washington Copolymères multiséquencés
EP2352522A4 (fr) 2008-11-06 2014-03-05 Univ Washington Véhicules d'administration intracellulaire bispécifique
US9593169B2 (en) 2008-12-08 2017-03-14 University Of Washington Omega-functionalized polymers, junction-functionalized block copolymers, polymer bioconjugates, and radical chain extension polymerization
US20100159010A1 (en) * 2008-12-24 2010-06-24 Mutual Pharmaceutical Company, Inc. Active Agent Formulations, Methods of Making, and Methods of Use
TWI374903B (en) * 2008-12-31 2012-10-21 Ind Tech Res Inst Biodegradable copolymer hydrogel materials
WO2011062965A2 (fr) 2009-11-18 2011-05-26 University Of Washington Through Its Center For Commercialization Monomères de ciblage et polymère ayant des blocs de ciblage
EP3027221A1 (fr) 2013-07-30 2016-06-08 PhaseRx, Inc. Copolymères séquencés et leur conjugués ou complexes avec des oligonucléotides
US11219634B2 (en) 2015-01-21 2022-01-11 Genevant Sciences Gmbh Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells
EP3426301A4 (fr) 2016-03-08 2019-11-06 Los Gatos Pharmaceuticals, Inc. Nanoparticules composites et utilisations desdites nanoparticules
US10407437B2 (en) 2016-03-08 2019-09-10 Los Gatos Pharmaceuticals, Inc. Camptothecin derivatives and uses thereof
CN106432647B (zh) * 2016-09-26 2018-10-30 华南理工大学 基于叔氨基的pH响应嵌段聚合物及其混合胶束与应用
WO2018126084A1 (fr) 2016-12-30 2018-07-05 Phaserx, Inc. Molécules de peg ramifié, compositions et procédés associés
WO2019032975A1 (fr) * 2017-08-10 2019-02-14 Mec Device Pharma International Llc Formulations de médicament anti-abus
CN114377144B (zh) * 2022-01-28 2024-10-29 南通大学 pH/活性氧双重响应性超分子聚肽前药纳米粒子

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1411843A (en) * 1973-02-28 1975-10-29 Univ Strathclyde Method of modifying the properties of a polymer
JPS5767860A (en) * 1980-10-15 1982-04-24 Fuji Photo Film Co Ltd Material for multilayer analysis
JP2517760B2 (ja) * 1989-05-11 1996-07-24 新技術事業団 水溶性高分子化医薬製剤
KR940003548U (ko) * 1992-08-14 1994-02-21 김형술 세탁물 건조기
US5840319A (en) * 1992-10-08 1998-11-24 Alakhov; Valery Yu Biological agent compositions
EP0639592A1 (fr) * 1993-08-18 1995-02-22 Nippon Shokubai Co., Ltd. Copolymères greffés soluble dans l'eau, et leur procédé de préparation
US5786387A (en) * 1994-03-23 1998-07-28 Meiji Seika Kabushiki Kaisha Lipid double-chain derivative containing polyoxyethylene
US5620850A (en) * 1994-09-26 1997-04-15 President And Fellows Of Harvard College Molecular recognition at surfaces derivatized with self-assembled monolayers
US5997861A (en) 1994-10-31 1999-12-07 Burstein Laboratories, Inc. Antiviral supramolecules containing target-binding molecules and therapeutic molecules bound to spectrin
US5656611A (en) * 1994-11-18 1997-08-12 Supratek Pharma Inc. Polynucleotide compositions
US6221959B1 (en) * 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
AU4690596A (en) 1994-12-30 1996-07-24 Chiron Viagene, Inc. Nucleic acid condensing agents with reduced immunogenicity
US5492996A (en) * 1995-02-21 1996-02-20 The United States Of America As Represented By The Secretary Of The Air Force Alcohol soluble benzazole polymers
JP3855279B2 (ja) * 1995-04-19 2006-12-06 一則 片岡 ヘテロテレケリックブロックコポリマーおよびその製造方法
US5908777A (en) * 1995-06-23 1999-06-01 University Of Pittsburgh Lipidic vector for nucleic acid delivery
AU726749B2 (en) * 1995-08-10 2000-11-16 Kazunori Kataoka Block polymer having functional groups on its both ends
US5770627A (en) * 1995-08-16 1998-06-23 University Of Washington Hydrophobically-modified bioadhesive polyelectrolytes and methods relating thereto
US5702717A (en) * 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
EP0894043B1 (fr) 1996-03-15 2001-10-31 President And Fellows Of Harvard College Procede de formation d'articles et de surfaces a motifs par micromoulage capillaire
US5955509A (en) * 1996-05-01 1999-09-21 Board Of Regents, The University Of Texas System pH dependent polymer micelles
WO1997049387A1 (fr) * 1996-06-27 1997-12-31 G.D. Searle And Co. Particules comprenant des copolymeres amphiphiles, possedant un domaine d'enveloppe reticulee et un domaine de noyau utiles et autres dans des applications pharmaceutiques
GB9623051D0 (en) 1996-11-06 1997-01-08 Schacht Etienne H Delivery of DNA to target cells in biological systems
EP1019064A4 (fr) 1997-02-28 2006-11-08 Univ California Inhibition de la liaison entre cellules au moyen d'ensembles lipidiques
EP0963758A3 (fr) 1998-05-07 2000-03-22 Universiteit Gent Synthetique polyaminoacide complexes pour l'apport des acides nucleiques aux celles cibles
US5939453A (en) * 1998-06-04 1999-08-17 Advanced Polymer Systems, Inc. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
TR200100254T2 (tr) * 1998-07-13 2001-06-21 Expression Genetics, Inc. Eriyebilir ve bakterilerle ayrışabilir bir gen iletim taşıyıcısı olarak poly-l-lysine benzeri bir poliyester.
DE19919785A1 (de) * 1999-04-30 2000-12-07 Wella Ag Haarbehandlungsmittel mit Polymeren aus ungesättigten Sacchariden, ungesättigten Saccharidsäuren oder deren Derivaten
DE10008895A1 (de) * 2000-02-25 2001-08-30 Beiersdorf Ag Stabilisierung oxidations- und/oder UV-empfindlicher Wirkstoffe
EP1286643A2 (fr) 2000-05-17 2003-03-05 Labopharm Inc. Methodes et compositions a base de micelles polymeres sensibles au ph, permettant d'augmenter la puissance d'agents therapeutiques
US6939564B2 (en) * 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
US6780428B2 (en) * 2001-06-08 2004-08-24 Labopharm, Inc. Unimolecular polymeric micelles with an ionizable inner core
GB0131112D0 (en) * 2001-12-31 2002-02-13 Univ London Pharmacy Block copolymers
WO2004035013A2 (fr) 2002-10-21 2004-04-29 L'oreal Procede de dissolution de composes lipophiles dans une solution aqueuse avec des copolymeres sequences amphiphiles, et compositions cosmetiques

Also Published As

Publication number Publication date
DE602004018772D1 (de) 2009-02-12
US20040072784A1 (en) 2004-04-15
PT1638539E (pt) 2009-04-09
BRPI0411872A (pt) 2006-08-08
SI1638539T1 (sl) 2009-10-31
CA2530736C (fr) 2013-07-02
WO2004112757A1 (fr) 2004-12-29
MXPA05014017A (es) 2007-01-31
EP1638539B1 (fr) 2008-12-31
AU2004248863A1 (en) 2004-12-29
US7094810B2 (en) 2006-08-22
JP2007505029A (ja) 2007-03-08
ES2323701T3 (es) 2009-07-23
EP1638539A1 (fr) 2006-03-29
AU2004248863B2 (en) 2009-03-12
CY1110264T1 (el) 2015-01-14
CA2530736A1 (fr) 2004-12-29
PL1638539T3 (pl) 2009-10-30
JP4619357B2 (ja) 2011-01-26
ATE418970T1 (de) 2009-01-15

Similar Documents

Publication Publication Date Title
DK1638539T3 (da) Farmaceutiske sammensætninger omfattende pH-sensitive blokcopolymerer og et hydrofobisk medikament
DE60044459D1 (de) IN ORGANISCHEN LÖSEMITTELN LÖSLICHE BIOLOGISCH ABBAUBARE POLY (ALKYLENOXID)- POLY (p-DIOXANON) BLOCKCOPOLYMERE SOWIE DIESE ENTHALTENDE ZUSAMMENSETZUNG ZUR ARZNEISTOFFVERABREICHUNG
ATE313586T1 (de) Mehrarmige blockcopolymere und pharmazeutische zusammensetzung
WO2003044076A8 (fr) Poly(ortho esters) bioerodables comprenant des groupes amines, et copolymeres en bloc les contenant
BR0213143A (pt) Composições lìquidas para administração oral contendo guaifenesina e um copolìmero de bloco polioxialquileno
EE200400033A (et) Vähelahustuvaid ja/või happetundlikke ravimeid janeutraliseeritud happelisi polümeere sisaldavad farmatseutilised kompositsioonid
CA2483282A1 (fr) Microemulsions polymeres
ATE363898T1 (de) Mizellares arzneistoffverabreichungssystem für hydrophobe arzneistoffe
BR0111016A (pt) Composições farmacêuticas de liberação sustentada para a administração parenteral de compostos hidrófilos biologicamente ativos
CA2430481A1 (fr) Composition permettant la liberation prolongee de medicaments hydrophobes, et procede d'elaboration correspondant
WO2005072343A3 (fr) Compositions pharmaceutiques aqueuses de 2,6-diisopropylphenol (propofol) et leurs utilisations
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
EA200300045A1 (ru) Композиция и лекарственная форма для задерживаемого желудочного выделения алендроната и/или других бис-фосфонатов
BR0307893A (pt) Formulação oftálmica com sistema de goma
DE60031286D1 (de) Polymere zusammensetzung zur lösung von schwer wasserlöslichen medikamenten und verfahren zu deren herstellung
DE60134245D1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
DE60231862D1 (de) Erodierbare polymere zur injektion
EP1291362A4 (fr) Combinaison d'acide folique et de polysaccharide, son procede de preparation et composition pharmaceutique contenant cette combinaison agissant comme principe actif
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
BR0213379A (pt) Formulação resistente a derramamento de mascaramento de gosto
EP1539109A4 (fr) Composition de micelle de copolymere sequence a capacites ameliorees d'incorporation et de liberation prolongee de medicament
HRP20090022T3 (hr) Farmaceutski pripravci koji sadrže askorbinsku kiselinu za liječenje gljivičnih superinfekcija i gljivičnih recidiva
DE60217903D1 (de) Flüssige pharmazeutische zusammensetzungen auf wasserbasis in suspensionsform zur oralen verabreichung von ibuprofen
UY27373A1 (es) Formulaciones de interferón beta-humano
PT1411956E (pt) Utilizacao de polissacaridos sobre-sulfatados como inibidores de vih